Cargando…
Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment
BACKGROUND: The conditions of diminished ovarian reserve and primary ovarian insufficiency, characterized by poor fertility outcomes, currently comprise a major challenge in reproductive medicine, particularly in vitro fertilization. Currently in the IVF industry, blastocyst developmental success ra...
Autores principales: | Sadruddin, Sheela, Barnett, Brian, Ku, Lowell, Havemann, Dara, Mucowski, Sara, Herrington, Richard, Burggren, Warren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549822/ https://www.ncbi.nlm.nih.gov/pubmed/33044971 http://dx.doi.org/10.1371/journal.pone.0239779 |
Ejemplares similares
-
Bivariate analysis of basal serum anti-Müllerian hormone measurements and human blastocyst development after IVF
por: Sills, E Scott, et al.
Publicado: (2011) -
Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
por: Wang, Shunping, et al.
Publicado: (2018) -
Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone
por: Jamil, Zehra, et al.
Publicado: (2016) -
The Correlations of Anti-Mullerian Hormone,
Follicle-Stimulating Hormone and Antral
Follicle Count in Different Age Groups
of Infertile Women
por: Barbakadze, Ludmila, et al.
Publicado: (2015) -
Serum anti-Müllerian hormone is a better predictor of ovarian response than FSH and age in IVF patients with endometriosis
por: Yoo, Ji Hee, et al.
Publicado: (2011)